Back
Akebia Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
AKBA
Akebia Therapeutics
Last Price:
$1.65
Seasonality Move:
14%
7 Day Trial
ALL ACCESS PASS
$
7
[Urgent Alert] This unique trade could land you 100% gains in 10 days
Discover how much you can make with this "Friday Phenomenon."-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.74 | Sell |
| 20-day SMA: | 1.97 | Sell |
| 50-day SMA: | 2 | Sell |
| 200-day SMA: | 1.68 | Sell |
| 8-day EMA: | 1.73 | Sell |
| 20-day EMA: | 1.85 | Sell |
| 50-day EMA: | 1.94 | Sell |
| 200-day EMA: | 1.75 | Sell |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 39.91 | Sell |
| Chaikin Money Flow: | 2751882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.69 - 2.25) | Sell |
| Bollinger Bands (100): | (1.77 - 2.19) | Sell |
Akebia Therapeutics Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 1.65 while AKBA 8-day simple moving average is 1.74, which is a Sell signal.
-
The stock price of AKBA is 1.65 while Akebia Therapeutics 20-day SMA is 1.97, which makes it a Sell.
-
Akebia Therapeutics 50-day simple moving average is 2.00 while AKBA share price is 1.65, making it a Sell technically.
-
AKBA stock price is 1.65 and Akebia Therapeutics 200-day simple moving average is 1.68, creating a Sell signal.
AKBA Technical Analysis vs Fundamental Analysis
Sell
30
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a SellThe current Akebia Therapeutics [AKBA] share price is $1.65. The Score for AKBA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
431M
Price in USD:
1.65
Share Volume:
4.8M
Akebia Therapeutics 52-Week Range
52-Week High:
2.89
52-Week Low:
0.80
Sell
30
Akebia Therapeutics (AKBA)
is a Sell
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?The Akebia Therapeutics stock price is 1.65 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is overvalued.
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 1.65 while AKBA 8-day exponential moving average is 1.73, which is a Sell signal.
-
The stock price of AKBA is 1.65 while Akebia Therapeutics 20-day EMA is 1.85, which makes it a Sell.
-
Akebia Therapeutics 50-day exponential moving average is 1.94 while AKBA share price is 1.65, making it a Sell technically.
-
AKBA stock price is 1.65 and Akebia Therapeutics 200-day simple moving average is 1.75, creating a Sell signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.09 per share, an increase this year of $0.11 per share, and an increase next year of $0.23 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Akebia Therapeutics is a Sell
-
Akebia Therapeutics Relative Strength Index (RSI) is 39.91, which suggest Akebia Therapeutics is oversold
-
The Bollinger Bands (25) for Akebia Therapeutics is (1.69 - 2.25), which suggest Akebia Therapeutics is a Sell
-
The Bollinger Bands (100) for Akebia Therapeutics is (1.77 - 2.19), which suggest Akebia Therapeutics is a Sell
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.